Skip to main content

Thromboembolism and Contraceptive Medication: Incidence and Mechanism

  • Chapter
Book cover Metabolic Effects of Gonadal Hormones and Contraceptive Steroids

Abstract

The nature of this morning’s meeting on blood and vascular changes resulting from contraceptive medication differs sharply from those previously held. Earlier we have considered significant biochemical changes resulting from contraceptive medication, changes which, in the main, appeared reversible or potentially reversible on discontinuation of medication and which were, generally speaking, clinically asymptomatic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Inman, W.H. and Vessey, M.P.: Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of childbearing age. Brit. Med. J. 2:193 (1968).

    Article  PubMed  CAS  Google Scholar 

  2. Vessey, M.P. and Doll, R.: Investigation of relation between use of oral contraceptives and thromboembolic disease. Brit. Med. J. 2:199 (1968).

    Article  PubMed  CAS  Google Scholar 

  3. Drill, V.A. and Calhoun, D.W.: Oral contraceptives and thromboembolic disease. J.A.M.A. 206:77 (1968).

    Article  PubMed  CAS  Google Scholar 

  4. The Veterans Administration Co-operative Urological Research Group. Treatment and survival of patients with cancer of the prostrate. Surg. Obstet. Gyn. 124: 1011 (1967).

    Google Scholar 

  5. Oliver, M.F. and Boyd, G.S.: Influence of reduction of serum lipids on prognosis of coronary heart-disease. A five year study using oestrogen. Lancet ii:499 (1961).

    Article  Google Scholar 

  6. Stamler, J., Pick, B., Katz, L.N., Pick, A., Berkson, D.M. and Century, D.: Effectiveness of oestrogens for therapy of myocardial infarction in middle-aged men. J. Am. Med. Assoc. 183: 632 (1963).

    CAS  Google Scholar 

  7. Daniel, D.G., Campbell, H. and Tumball, A.C.: Puerperal thromboembolism and suppression of lactation. Lancet ii:287 (1967).

    Article  Google Scholar 

  8. Jeffcoate, T.N.A., Miller, J., Roos, R.F. and Tindall, V.B.:Puerpal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Brit. Med. J. 4:19 (1968).

    Article  PubMed  CAS  Google Scholar 

  9. Mustard, J.F., Roswell, H.C. and Murphy, E.A.: Thrombosis. Amer. J. Med. Sci. 248:469 (1964).

    Article  PubMed  CAS  Google Scholar 

  10. Mustard, J.F. and Packman, M.A.: The biochemistry of primary hemostasis. Page 306 in Plenary Session Papers XII. Congress International Society of Hematology, New York, (1968).

    Google Scholar 

  11. Mitchell, J. R. A.: The pathogenesis of thrombosis. Page 321 in Plenary Session Papers XII. Congress International Society of Hematology, New York (1968).12.

    Google Scholar 

  12. Esnouf, M.P.: Biochemical aspects of blood coagulation. Page 315 in Plenary Session Papers XII. Congress International Society of Hematology, New York (1968).

    Google Scholar 

  13. Crumb, J.D, and Ratnoff, O.D.: Activation of Hageman factor by solutions of ellagic acid. J. Lab. Clin. Med. 62:1006 (1963).

    Google Scholar 

  14. Sise, H.: Anovulatory hormones and blood coagulation. In Blood Coagulation, Thrombosis and Female Hormones. Editors: T. Astrup and I.S. Wright, James F. Mitchell Foundation, Washington, D.C., 1968, p. 19.

    Google Scholar 

  15. Owen, C.A., Thompson, J.H., Jr., Bowie, W., Didisheim, P. and Spittell, J.A.: Coagulation studies during pregnancy and hormone treatment. In Blood Coagulation, Thrombosis and Female Hormones. Editors: T. Astrup and I.S. Wright. James F. Mitchell Foundation, Washington, D.C., 1968, p. 24.

    Google Scholar 

  16. Poller, L., Tabiowa, A. and Thompson, J.M.: Effects of low-dose oral contraceptives on blood coagulation. Brit. Med. J. 2:218 (1968).

    Article  Google Scholar 

  17. Gormsen, J., Fletcher, A.P., Alkjaersig, N. and Sherry, S.: Enzymatic lysis of plasma clots: the influence of fibrin stabilization on lysis rates. Archives of Biochem. and Biophys. 120:654 (1967).

    Article  CAS  Google Scholar 

  18. Coopland, A., Fletcher, A.P. and Alkjaersig, N.: Reduction of plasma factor XIII (fibrin stabilizing factor) concentration during pregnancy. J. Lab. Clin. Med. (In Press).

    Google Scholar 

  19. Fletcher, A.P.: The problem of intravascular fibrinolytic reaction. In Platelets: Their Role in Hemostasis and Thrombosis. Editors: K.M. Brinkhous, I.S. Wright, J.P. Samlier, H.R. Roberts and S. Hinnon. Thromb. et diath. Haemorrh. Suppl. 26:343 (1967).

    Google Scholar 

  20. Fletcher, A.P. and Alkjaersig, N.: Plasma fibrinogen and hemostatic function (pathological and genetic disorders) Progress in Hematology (Editors: E.B. Brown and C.V. Moore), 5:246 (1966).

    Google Scholar 

  21. Allison, A.C. and Humphrey, J.H.: A theoretical and experimental analysis of double diffusion precipitin reaction in gels and its application characterization of antigens. Immunology 3:95 (1960).

    PubMed  CAS  Google Scholar 

  22. Alkjaersig, N., Fletcher, A.P. and Bachmann, F.: In Preparation.

    Google Scholar 

  23. Scheraga, H.A. and Laskowski, M., Jr.: The fibrinogen- fibrin conversion. Advances in Protein Chemistry 12: 1(1957).

    Article  CAS  Google Scholar 

  24. Alkjaersig, N., Fletcher, A.P. and Sherry, S.: The mechanism of clot dissolution by plasmin. J. Clin. Invest. 38: 1086 (1959).

    Article  PubMed  CAS  Google Scholar 

  25. Fletcher, A.P., Alkjaersig, N. and Sherry, S.: Fibrinolytic mechanisms and the development of thrombolytic therapy. Am. J. Med. 33:738 (1962).

    Article  PubMed  CAS  Google Scholar 

  26. Fletcher, A.P.: Measurement of plasma thrombolytic activity:isotopic method. In Blood Coagulation, Hemorrhage and Thrombosis:Methods of Study. Editors: L.A. Kazal and L.M. Tocantins. Grune and Stratton, 1964, p. 254.

    Google Scholar 

  27. Sawyer, W.D., Fletcher, A.P., Alkjaersig, N. and Sherry, S.: Studies on the thrombolytic activity of human plasma. J. Clin. Invest. 39:426 (1960).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1969 Plenum Press, New York

About this chapter

Cite this chapter

Fletcher, A.P., Alkjaersig, N. (1969). Thromboembolism and Contraceptive Medication: Incidence and Mechanism. In: Salhanick, H.A., Kipnis, D.M., Wiele, R.L.V. (eds) Metabolic Effects of Gonadal Hormones and Contraceptive Steroids. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1782-1_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1782-1_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1784-5

  • Online ISBN: 978-1-4684-1782-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics